Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot HSCT with post-transplant cyclophosphamide and low-dose ATG from HLA-mismatched related donors for non-malignant diseases
jRCTs031180397Completed
- Sponsor
- National Center for Child Health and Development
- Start
- Apr 2017
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Open-label, single-arm trial of cyclophosphamide and antithymocyte globulin rabbit in bone marrow failure, Immunogenetic disorder and Congenital Metabolic Diseases, sponsored by National Center for Child Health and Development. Primary endpoint: Incidence of composite events by day 30. Started Apr 2017; status: completed.
02
Drugs
cyclophosphamideantithymocyte globulin rabbit
03
Conditions
bone marrow failureImmunogenetic disorderCongenital Metabolic Diseases
Beyond the preview
Go deeper on jRCTs031180397.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031180397.